The U.S. PDA Registry

Not yet recruitingOBSERVATIONAL
Enrollment

5,000

Participants

Timeline

Start Date

January 1, 2020

Primary Completion Date

January 1, 2030

Study Completion Date

December 1, 2031

Conditions
Ductus Arteriosus, Patent
Interventions
DEVICE

Transcatheter PDA Closure

Device utilized for closure of PDA, study is to help assure continued safety and effectiveness of FDA approved Amplatzer Piccolo Occluder device as well as other devices used off label for PDA closure in premature infants less than 2 kg at the time of device implant.

Trial Locations (1)

38103

LeBonheur Children's Hospital, Memphis

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Abbott

INDUSTRY

lead

Le Bonheur Children's Hospital

OTHER